Case Reports in Medicine underlying mood disorder. His reaction seemed to be clearly dose-related and dependent also on the use of long-acting methylphenidate. Acknowledgment Research grants from the Finnish Sleep Research Society and the University of Helsinki to Tuuli Lahti. References [1] A. J. Bobb, F. X. Castellanos, A. M. Addington, and J. L. Rapoport, “Molecular genetic studies of ADHD: 1991 to 2004,” American Journal of Medical Genetics Part B, vol. 132, no. 1, pp. 109–125, 2005. [2] T. Torgersen, B. Gjervan, and K. Rasmussen, “ADHD in adults: a study of clinical characteristics, impairment and comorbidity,” Nordic Journal of Psychiatry, vol. 60, no. 1, pp. 38–43, 2006. [3] J. D. Ball, M. Tiernan, J. Janusz, and A. Furr, “Sleep patterns among children with attention-deﬁcit hyperactivity disorder: a reexamination of parent perceptions,” Journal of Pediatric Psychology, vol. 22, no. 3, pp. 389–398, 1997. [4] R. B. Sangal, J. Owens, A. J. Allen, V. Sutton, K. Schuh, and D. Kelsey, “Eﬀects of atomoxetine and methylphenidate on sleep in children with ADHD,” Sleep, vol. 29, no. 12, pp. 1573–1585, 2006. [5] J. Epstein, D. E. Johnson, and C. K. Conners, Conners’ Adult ADHD Diagnostic Interview for DSM-IV (CAADID), Multi- Health Systems, Toronto, Canada, 2001. [6] M. B. First, R. L. Spitzer, M. Gibbon, and J. B. W. Williams, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID- I/P W/PSY SCREEN), Biometrics Research, New York State Psychiatric Institute, New York, NY, USA, November 2002. [7] M. B. First, R. L. Spitzer, M. Gibbon, and J. B. W. Williams, Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II), American Psychiatric Press, Washington, DC, USA, 1997. [8] T. A. Wehr, D. Sack, N. Rosenthal, W. Duncan, and J. C. Gillin, “Circadian rhythm disturbances in manic-depressive illness,” Federation Proceedings, vol. 42, no. 11, pp. 2809–2814, 1983. [9] G. Katz, H. Y. Knobler, Z. Laibel, Z. Strauss, and R. Durst, “Time zone change and major psychiatric morbidity: the results of a 6-year study in Jerusalem,” Comprehensive Psychia- try, vol. 43, no. 1, pp. 37–40, 2002. [10] E. Frangos, G. Athanassenas, and S. Tsitourides, “Seasonality of the episodes of recurrent aﬀective psychoses: possible prophylactic interventions,” Journal of Aﬀective Disorders, vol. 2, no. 4, pp. 239–247, 1980. [11] T. Roenneberg and M. Merrow, “Circadian clocks—the fall and rise of physiology,” Nature Reviews Molecular Cell Biology, vol. 6, no. 12, pp. 965–971, 2005. [12] A. P. Wingo and S. N. Ghaemi, “Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients,” Psychopharmacology Bulletin, vol. 41, pp. 37–47, 2008. [13] S. H. Jones, D. J. Hare, and K. Evershed, “Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder,” Bipolar Disorders, vol. 7, no. 2, pp. 176–186, 2005. [14] A. Millar, C. A. Espie, and J. Scott, “The sleep of remitted bipolar outpatients: a controlled naturalistic study using 3 actigraphy,” Journal of Aﬀective Disorders, vol. 80, no. 2-3, pp. 145–153, 2004. [15] D. T. Plante and J. W. Winkelman, “Sleep disturbance in bipolar disorder: therapeutic implications,” American Journal of Psychiatry, vol. 165, no. 7, pp. 830–843, 2008.